Brought to you by 
Drug delivery player Corium's IPO nets $48.4mm
03 Apr 2014
Executive Summary
Corium International Inc. (drug delivery technologies) netted $48.4mm in its IPO of 6.5mm shares at $8. The company sold more than the 5.5mm shares planned, but way below its $10-12 price range.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
- Vaccines
-
Drug Delivery
- Macromolecule
- Transdermal
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Drug delivery player Corium's IPO nets $48.4mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice